Affiliation:
1. LL Silver Consulting, LLC, 955 S. Springfield Ave., Unit C403, Springfield, New Jersey 07081
Abstract
SUMMARY
The discovery of novel small-molecule antibacterial drugs has been stalled for many years. The purpose of this review is to underscore and illustrate those scientific problems unique to the discovery and optimization of novel antibacterial agents that have adversely affected the output of the effort. The major challenges fall into two areas: (i) proper target selection, particularly the necessity of pursuing molecular targets that are not prone to rapid resistance development, and (ii) improvement of chemical libraries to overcome limitations of diversity, especially that which is necessary to overcome barriers to bacterial entry and proclivity to be effluxed, especially in Gram-negative organisms. Failure to address these problems has led to a great deal of misdirected effort.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health,General Immunology and Microbiology,Epidemiology
Reference405 articles.
1. Ackermann, B. L., B. T. Regg, L. Colombo, S. Stella, and J. E. Coutan. 1996. Rapid analysis of antibiotic-containing mixtures from fermentation broths by using liquid chromatography-electrospray ionization-mass spectrometry and matrix-assisted laser desorption ionization-time-of-flight-mass spectrometry. J. Am. Soc. Mass Spectrom. 7 : 1227-1237.
2. Adamek, R. J., S. Suerbaum, B. Pfaffenbach, and W. Opferkuch. 1998. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin—influence on treatment outcome. Am. J. Gastroenterol. 93 : 386-389.
3. Agarwal, A., S. Louise-May, J. A. Thanassi, S. D. Podos, J. Cheng, C. Thoma, C. Liu, J. A. Wiles, D. M. Nelson, A. S. Phadke, B. J. Bradbury, M. S. Deshpande, and M. J. Pucci. 2007. Small molecule inhibitors of E. coli primase, a novel bacterial target. Bioorg. Med. Chem. Lett. 17 : 2807-2810.
4. Ali, A., G. E. Taylor, K. Ellsworth, G. Harris, R. Painter, L. L. Silver, and K. Young. 2003. Novel pyrazolo[3,4-d]pyrimidine-based inhibitors of Staphylococcus aureus DNA polymerase III: design, synthesis, and biological evaluation. J. Med. Chem. 46 : 1824-1830.
5. Allen, N. E. 2010. From vancomycin to oritavancin: the discovery and development of a novel lipoglycopeptide antibiotic. Anti Infect. Agents Med. Chem. 9 : 23-47.
Cited by
1069 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献